Human Parvovirus Infections

Infectious Diseases of the Fetus and Newborn Infant

Volumn , Issue , 2006, Pages 867-892

  Adler, Stuart P ^a   Koch, William C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247592071     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160537-0/50029-3     Document Type: Chapter

References (300)

1. Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses 1995, Springer-Verlag, New York. F.A. Murphy, C.M. Fauquet, D.H.L. Bishop (Eds.).
2. Torok TJ Unusual clinical manifestations reported in patients with parvovirus B19 infection. Human Parvovirus B19. Monographs in Virology 1997, vol. 20:61-92. Karger, Basel.
3. Koch WC Fifth (human parvovirus B19) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 2001, 14:343.
4. Cossart YE, Field AM, Cant B, Widdows D Parvovirus-like particles in human sera. Lancet 1975, 1:72.
5. Summers J, Jones SE, Anderson MJ Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. J Gen Virol 1983, 64:2527.
6. Pattison JR, Jones SE, Hodgson J Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Letter. Lancet 1981, 1:664.
7. Serjeant GR, Topley JM, Mason K, et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet 1981, 2:595.
8. Anderson MJ, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Letter. Lancet 1983, 1:1378.
9. Thurn J Human parvovirus B19: historical and clinical review. Rev Infect Dis 1988, 10:1005.
10. Ager EA, Chin TDY, Poland JD Epidemic erythema infectiosum. N Engl J Med 1966, 275:1326.
11. Cramp JE, Armstrong BDJ Erythema infectiosum: no evidence of teratogenicity. Br Med J 1977, 2:1031.
12. Pattison JR B19 Virus infections in pregnancy. Parvoviruses and Human Disease 1988, 133-138. CRC Press, Boca Raton, Fla,. J.R. Pattison (Ed.).
13. Siegel G Patterns of parvovirus disease in animals. Parvoviruses and Human Disease 1988, 43-68. CRC Press, Boca Raton, Fla. J.R. Pattison (Ed.).
14. Brown T, Anand A, Ritchie LD, et al. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984, 2:1033.
15. Knott PD, Welply GAC, Anderson MJ Serologically proved intrauterine infection with parvovirus. Letter. BMJ 1984, 289:1960.
16. Anand A, Gray ES, Brown T, et al. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987, 316:183.
17. Kinney JS, Anderson LJ, Farrar J, et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 1988, 157:663.
18. Hall SM Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 1990, 300:1166.
19. Adler SP, Manganello AM, Koch WC, et al. Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 1993, 168:361.
20. Gratacos E, Torres P-J, Vidal J, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995, 171:1360.
21. Koch WC, Harger JH, Barnstein B, Adler SP Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B10 with a primary maternal infection during pregnancy. Pediatr Infect Dis 1998, 17:489.
22. Pringle CR Virus taxonomy update. Arch Virol 1993, 133:491.
23. Astell CR, Weixing L, Brunstein J, St Amand J B19 parvovirus: biochemical and molecular features. Monographs in Virology, vol. 20. Human Parvovirus B19 1997, 16-41. Karger, Basel. L.J. Anderson, N.S. Young (Eds.).
24. O'Sullivan MG, Anderson DC, Fikes JD, et al. Identification of a novel simian parvovirus from cynomolgus monkey with severe anemia: a paradigm for human B19 parvovirus infection. J Clin Invest 1994, 93:1571.
25. Mori J, Beattie P, Melton DW, et al. Structure and mapping of the DNA of human parvovirus B19. J Gen Virol 1987, 68:2797.
26. Umene K, Nunoue T Genetic diversity of human parvovirus B19 determined using a set of restriction endonucleases recognizing four or five base pairs and partial nucleotide sequencing: use of sequence variability in virus classification. J Gen Virol 1991, 72:1997.
27. Gallinella G, Venturoli S, Manaresi E, et al. B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol 2003, 76:9124.
28. Nguyen QT, Sifer C, Schneider V, et al. Novel human erythrovirus associated with transient aplastic crisis. J Clin Microbiol 1999, 37:2483.
29. Nguyen QT, Wong S, Heegaard ED, Brown KE Identification and characterization of a second human erythrovirus variant, A6. Virology 2002, 30:374.
30. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002, 76:9124.
31. Ozawa K, Ayub J, Kajigaya S, et al. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 1988, 62:2884.
32. Moffat S, Yaegashi N, Tada K, et al. Human parvovirus B19 nonstructural protein NS1 induces apoptosis in erythroid lineage cells. J Virol 1998, 72:3018.
33. Sol N, Le Junter J, Vassias I, et al. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by parvovirus B19. J Virol 1999, 73:8762.
34. Ozawa K, Kurtzman G, Young N Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986, 233:883.
35. Srivastava A, Lu L Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells form normal human bone marrow. J Virol 1988, 62:3059.
36. Yaegashi N, Shiraishi H, Takeshita T, et al. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol 1989, 63:2422.
37. Takahahsi T, Ozawa K, Mitani K, et al. B19 parvovirus replicates in erythroid leukemic cells in vitro. J Infect Dis 1989, 160:548.
38. Miyagawa E, Yoshida T, Yamaguchi K, et al. Infection of the erythroid cell line KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J Virol Methods 1999, 83:45.
39. Brown KE, Young NS, Liu JM Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994, 16:1.
40. Brown KE, Anderson SM, Young NS Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993, 262:114.
41. Brown KE, Hibbs JR, Gallinella G, et al. Resistance to parvovirus B19 infection due to a lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994, 330:1192.
42. Weigel-Kelley KA, Yoder MC, Srivastava A Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 2001, 75:4110.
43. Weigel-Kelley KA, Yoder MC, Srivastava A Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta 1 integrin for viral entry. Blood 2003, 102:3927.
44. Brown KE, Young NS Parvovirus B19 infection and hematopoiesis. Blood Rev 1995, 9:176.
45. Srivastava A, Bruno E, Briddell R, et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990, 76:1997.
46. Young N Hematologic and hematopoietic consequences of B19 infection. Semin Hematol 1988, 25:159.
47. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvovirus infection in humans. J Infect Dis 1985, 152:257.
48. Moffat S, Tanaka N, Tada K, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996, 70:8485.
49. Teuscher T, Baillod B, Holzer BR Prevalence of human parvovirus B19 in sickle cell disease and healthy controls. Trop Geogr Med 1991, 43:108.
50. Schwarz TF, Gürtler LG, Zoulek G, et al. Seroprevalence of human parvovirus B19 infection in São Tomé and Principe, Malawi and Mascarene Islands. Zentralbl Bakteriol 1989, 271:231.
51. Jones PH, Pickett LC, Anderson MJ, Pasvol G Human parvovirus infection in children and severe anaemia seen in an area endemic for malaria. J Trop Med Hyg 1990, 93:67.
52. de Freitas RB, Wong D, Boswell F, et al. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil. J Med Virol 1990, 32:203.
53. Brown CS, Jensen T, Meloen RH, et al. Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle. J Virol 1992, 66:69.
54. Morey AL, O'Neill HJ, Coyle PV, Fleming KA Immunohistological detection of human parvovirus B19 in formalin-fixed, paraffin-embedded tissues. J Pathol 1992, 166:105.
55. Loughrey AC, O'Neill HJ, Coyle PV, DeLeys R Identification and use of a neutralizing epitope of parvovirus B19 for the rapid detection of virus infection. J Med Virol 1993, 39:97.
56. Morinet F, Tratschin JD, Perol Y, Siegl G Comparison of 17 isolates of the human parvovirus B19 by restriction enzyme analysis. Arch Virol 1986, 90:165.
57. Umene K, Nunoue T The genome type of human parvovirus B19 strains isolated in Japan during 1981 differs from types detected in 1986 to 1987: a correlation between genome type and prevalence. J Gen Virol 1990, 71:983.
58. Umene K, Nunoue T Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia. J Med Virol 1993, 39:333.
59. Lawton AL, Smith RE Erythema infectiosum: a clinical study of an epidemic in Branford, Connecticut. Arch Intern Med 1931, 47:28.
60. Chargin L, Sobel N, Goldstein H Erythema infectiosum: report of an extensive epidemic. Arch Dermatol Syphilol 1943, 47:467.
61. Galvon FAC An outbreak of erythema infectiosum-Nova Scotia. Can Dis Wkly Rep 1983, 9:69.
62. Serjeant GR, Serjeant BE, Thomas PW, et al. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993, 341:1237.
63. Oliveira SA, Camacho LA, Pereira AC, et al. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niteroi city area, State of Rio de Janeiro, Brazil). Mem Inst Oswaldo Cruz 2002, 97:965.
64. Yamashita K, Matsunaga Y, Taylor-Wiedeman J, Yamazaki S A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol 1992, 45:49.
65. Naides SJ Erythema infectiosum (fifth disease) occurrence in Iowa. Am J Public Health 1988, 78:1230.
66. Cohen BJ, Buckley MM The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988, 25:151.
67. Nascimento JP, Buckley MM, Brown KE, Cohen BJ The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 1990, 32:41.
68. Edelson RN, Altman RA Erythema infectiosum: a statewide outbreak. J Med Soc N J 1970, 67:805.
69. Werner GH, Brachman PS, Ketler A, et al. A new viral agent associated with erythema infectiosum. Ann N Y Acad Sci 1957, 67:338.
70. Greenwald P, Bashe WJ An epidemic of erythema infectiosum. Am J Dis Child 1964, 107:30.
71. Yaegashi N, Okamura K, Hamazaki Y, et al. Prevalence of anti-human parvovirus antibody in pregnant women. Nippon Sanka Fujinka Gakkai Zasshi 1990, 42:162.
72. Koch WC, Adler SP Human parvovirus B19 infections in women of childbearing age and within families. Pediatr Infect Dis J 1989, 8:83.
73. Cohen BJ, Mortimer PP, Pereira MS Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) 1983, 91:113.
74. Schwarz TF, Roggendorf M, Deinhardt F Häufigkeit der parovirus-B19-infektionen. Seroepidemiologishe untersuchungen. Dtsch Med Wochenschr 1987, 112:1526.
75. Bartolomei Corsi O, Assi A, Morfini M, et al. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988, 25:165.
76. Eiffert H, Köchel HG, Heuer M, et al. Expression of an antigenic polypeptide of the human parvovirus B19. Med Microbiol Immunol 1990, l79:169.
77. Brown CS, van Bussel MJA, Wassenaar ALM, et al. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. J Virol Methods 1990, 29:53.
78. Rollag H, Patou G, Pattison JR, et al. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 1991, 23:675.
79. Salimans MMM, van Bussel MJA, Brown CS, Spaan WJM Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay. J Virol Methods 1992, 39:247.
80. Abraham M, Rudraraju R, Kannangai R, et al. A pilot study on the seroprevalence of parvovirus B19 infection. Indian J Med Res 2002, 115:139.
81. Schwarz TF, Hottenträger B, Roggendorf M Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals. Int J Med Microbiol Virol Parasitol Infect Dis 1992, 276:437.
82. Lin KH, You SL, Chen CJ, et al. Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol 1999, 57:169.
83. Couroucé AM, Ferchal F, Morinet F, et al. Parvovirus (SPLV) et antigène Aurillac. Rev Fr Transfus Immunohematol 1984, 27:5.
84. Cossart Y Parvovirus B19 finds a disease. Letter. Lancet 1981, 2:988.
85. O'Neill HJ, Coyle PV Two anti-parvovirus B19 IgM capture assays incorporating a mouse monoclonal antibody specific for B19 viral capsid proteins VP1 and VP2. Arch Virol 1992, 123:125.
86. Cohen BJ, Field AM, Gudnadottir S, et al. Blood donor screening for parvovirus B19. J Virol Methods 1990, 30:233.
87. da Silva Cruz A, Serpa MJA, Barth OM, Nascimento JP Detection of the human parvovirus B19 in a blood donor plasma in Rio de Janeiro. Mem Inst Oswaldo Cruz 1989, 84:279.
88. McOmish F, Yap PL, Jordan A, et al. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993, 31:323.
89. Yaegashi N, Shiraishi H, Tada K, et al. Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro. J Virol Methods 1989, 26:171.
90. Naides SJ, Scharosch LL, Foto F, Howard EJ Rheumatologic manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 1990, 33:1297.
91. Martinez-Campillo F, Lopez J, Verdu M, et al. Parvovirus B19 outbreak in a rural community in Alicante. Enferm Infect Microbiol Clin 2002, 20:376.
92. Abarca K, Cohen BJ, Vial PA Seroprevalence of parvovirus B19 in urban Chilean children and young adults, 1990 and 1996. Epidemiol Infect 2002, 128:59.
93. Smith-Whitley K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood 2004, 103:422.
94. Plummer FA, Hammond GW, Forward K, et al. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 1985, 313:74.
95. Chorba T, Coccia P, Holman RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986, 154:383.
96. Mortimer PP Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. J Clin Pathol 1983, 36:445.
97. Saarinen UA, Chorba TL, Tattersall P, et al. Human parvovirus B19 induced epidemic red-cell aplasia in patients with hereditary hemolytic anemia. Blood 1986, 67:1411.
98. Valeur-Jensen A, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999, 281:1099.
99. Anderson MJ, Lewis E, Kidd IM, et al. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 1984, 93:85.
100. Tuckerman JG, Brown T, Cohen BJ Erythema infectiosum in a village primary school: clinical and virological studies. J R Coll Gen Pract 1986, 36:267.
101. Morgan-Capner P, Wright J, Longley JP, Anderson MJ Sex ratio in outbreaks of parvovirus B19 infection. Letter. Lancet 1987, 2:98.
102. Mansfield F Erythema infectiosum: slapped face disease. Aust Fam Physician 1988, 17:737.
103. Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989, 149:1153.
104. Turner A, Olojugba O Erythema infectiosum in a primary school: investigation of an outbreak in Bury. Public Health 1989, 103:391.
105. Grilli EA, Anderson MJ, Hoskins TW Concurrent outbreaks of influenza and parvovirus B19 in a boys' boarding school. Epidemiol Infect 1989, 103:359.
106. Gillespie SM, Cartter ML, Asch S, et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA 1990, 263:2061.
107. Anderson LJ, Gillespie SM, Török TJ, et al. Risk of infection following exposures to human parvovirus B19. Behring Inst Mitt 1990, 85:60.
108. Rice PS, Cohen BJ A school outbreak of parvovirus B19 infection investigated using salivary antibody assays. Epidemiol Infect 1996, 6:331.
109. Bell LM, Naides SJ, Stoffman P, et al. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989, 321:485.
110. Pillay D, Patou G, Hurt S, et al. Parvovirus B19 outbreak in a children's ward. Lancet 1992, 339:107.
111. Cohen BJ, Couroucé AM, Schwarz TF, et al. Laboratory infection with parvovirus B19. Letter. J Clin Pathol 1988, 41:1027.
112. Shiraishi H, Sasaki T, Nakamura M, et al. Laboratory infection with human parvovirus B19. Letter. J Infect 1991, 22:308.
113. Evans JPM, Rossiter MA, Kumaran TO, et al. Human parvovirus aplasia: case due to cross infection in a ward. BMJ 1984, 288:681.
114. Ueda K, Akeda H, Tokugawa K, Nishima S Human parvovirus infection. Letter. N Engl J Med 1986, 314:645.
115. Pillay D, Patou G, Rees L, Griffiths PD Secondary parvovirus B19 infection in an immunocompromised child. Pediatr Infect Dis J 1991, 10:623.
116. Lui SL, Luk WK, Cheung CY, et al. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 2001, 71:59.
117. Miyamoto K, Ogami M, Takahashi Y, et al. Outbreak of human parvovirus B19 in hospital workers. J Hosp Infect 2000, 45:238.
118. Koziol DE, Kurtzman G, Ayub JA, et al. Nosocomial human parvovirus B19 infection: lack of transmission from a chronically infected patient to hospital staff. Infect Control Hosp Epidemiol 1992, 13:343.
119. Dowell SF, Torok TJ, Thorp JA, et al. Parvovirus B19 infection in hospital workers: community or hospital acquisition?. J Infect Dis 1995, 172:1076.
120. Carter ML, Farley TA, Rosengren S, et al. Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis 1991, 163:282.
121. Ray SM, Erdman DD, Berschling JD, et al. Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers. Infect Control Hosp Epidemiol 1997, 18:109.
122. Patou G, Pillay D, Myint S, Pattison J Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol 1993, 31:540.
123. Potter CG, Potter AC, Hatton CSR, et al. Variation of erythroid and myeloid precursors in the marrow of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987, 79:1486.
124. Morey AL, Porter HJ, Keeling JW, Fleming KA Non-isotopic in situ hybridisation and immunophenotyping of infected cells in investigation of human fetal parvovirus infection. J Clin Pathol 1992, 45:673.
125. Mortimer PP, Luban NLC, Kelleher JF, Cohen BJ Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 1983, 2:482.
126. Lyon DJ, Chapman CS, Martin C, et al. Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Letter. Lancet 1989, 1:1085.
127. Williams MD, Cohen BJ, Beddall AC, et al. Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang 1990, 58:177.
128. Morfini M, Longo G, Rossi Ferrini P, et al. Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus. Letter. Am J Hematol 1992, 39:149.
129. Zakrzewska K, Azzi A, Patou G, et al. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992, 81:407.
130. Schwarz TF, Roggendorf M, Hottenträger B, et al. Removal of parvovirus B19 from contaminated factor VIII during fractionation. J Med Virol 1991, 35:28.
131. Azzi A, Ciappi S, Zakrzewska K, et al. Human parvovirus B19 infection in hemophiliacs infused with two high purity, virally attenuated factor VIII concentrates. Am J Hematol 1992, 39:228.
132. Anderson MJ Rash illness due to B19 virus. Parvoviruses and Human Disease 1988, 93-104. CRC Press, Boca Raton, Fla. J.R. Pattison (Ed.).
133. Anderson LJ Role of parvovirus B19 in human disease. Pediatr Infect Dis 1987, 6:711.
134. Garcia-Tapia AM, Fernandez-Guitierrez del Alamo C, Giron JA, et al. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain. Clin Infect Dis 1995, 21:424.
135. Zerbini M, Musiani M, Venturoli S, et al. Different syndromes associated with B19 parvovirus viraemia in paediatric patients: report of four cases. Eur J Pediatr 1992, 151:815.
136. Tsuda H, Maeda Y, Nakagawa K Parvovirus B19-related lymphadenopathy. Br J Haematol 1993, 85:631.
137. Brown KE Human parvovirus B19 epidemiology and clinical manifestations. Monographs in Virology 1997, vol. 20:42-60. Karger, Basel.
138. Lefrere J-J, Courouce A-M, Soulier JP, et al. Henoch-Schönlein purpura and human parvovirus infection. Pediatrics 1986, 78:183.
139. Saunders PWG, Reid MM, Cohen BJ Human parvovirus induced cytopenias: a report of five cases. Br J Haematol 1986, 63:407.
140. Lefrere JJ, Courouce AM, Kaplan C Parvovirus and idiopathic thrombocytopenic purpura. Letter. Lancet 1989, 1:279.
141. Török TJ Parvovirus B19 and human disease. Adv Int Med 1992, 37:431.
142. White DG, Woolf AD, Mortimer PP, et al. Human parvovirus arthropathy. Lancet 1985, 1:419.
143. Naides SJ, Field EH Transient rheumatoid factor positivity in acute human parvovirus B19 infection. Arch Intern Med 1988, 148:2587.
144. Reid DM, Reid TMS, Brown T, et al. Human parvovirus-associated with arthritis: a clinical and laboratory description. Lancet 1985, 1:422.
145. Nocton JJ, Miller LC, Tucker LB, Schaller JG Human parvovirus B19-associated arthritis in children. J Pediatr 1993, 122:186.
146. Dijkmans BA, van Elsacker-Niele Am, Salimans MMM, et al. Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum 1988, 31:279.
147. Saal JG, Stendle M, Einsele H, et al. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatology 1992, 12:147.
148. Mimori A, Misaki Y, Hachiya T, et al. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis. Rheumatol Int 1994, 14:87.
149. Soderlund M, von Essen R, Haapasaari J, et al. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997, 349:1063.
150. Stahl HD, Hubner B, Seidl B, et al. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis 2000, 59:342.
151. Kerr JR Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 2000, 59:672.
152. Koch WC, Massey G, Russell EC, et al. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr 1990, 116:355.
153. Van Horn DK, Mortimer PP, Young N, et al. Human parvovirus-associated red cell aplasia in the absence of hemolytic anemia. Am J Pediatr Hematol Oncol 1986, 8:235.
154. Kurtzman GJ, Ozawa K, Cohen B, et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987, 317:287.
155. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990, 113:926.
156. Weiland HT, Salimans MMM, Fibbe WE, et al. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant recipient. Letter. Br J Haematol 1989, 71:300.
157. Kurtzman G, Frickhofen N, Kimball J, et al. Pure red-cell aplasia of ten years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989, 321:519.
158. Muir K, Todd WTA, Watson WH, et al. Viral-associated haemophagocytosis with parvovirus B19-related pancytopenia. Lancet 1992, 339:1139.
159. Wong TY, Chan PK, Leung CB, et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999, 34:1119.
160. Geetha D, Zachary JB, Baldado HM, et al. Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of the literature. Clin Transplant 2000, 14:586.
161. Pamidi S, Friedman K, Kampalath B, et al. Human parvovirus infection presenting as persistent anemia in renal transplant recipients. Transplantation 2000, 69:2666.
162. Zolnourian ZR, Curran MD, Rima BK, et al. Parvovirus B19 in kidney transplant patients. Transplantation 2000, 69:2198.
163. Seishima M, Kanoh H, Izumi T The spectrum of cutaneous eruptions in 22 patients with isolated serological evidence of infection by parvovirus B19. Arch Dermatol 1999, 135:1556.
164. Lefrere JJ, Courouce AM, Bertrand Y, et al. Human parvovirus and aplastic crisis in chronic hemolytic anemias: a study of 24 observations. Am J Hematol 1986, 23:271.
165. Finkel TH, Torok TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?. Lancet 1994, 343:1255.
166. Schwarz TF, Wiersbitzky S, Pambor M Case report: detection of parvovirus B19 in skin biopsy of a patient with erythema infectiosum. J Med Virol 1994, 43:171.
167. Magro CM, Dawood MR, Crowson AN The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol 2000, 31:488.
168. Ferguson PJ, Saulsbury FT, Dowell SF, et al. Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura. Arthritis Rheum 1996, 39:880.
169. Smith PT, Landry ML, Carey H, et al. Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review. Clin Infect Dis 1997, 27:164.
170. Grilli R, Izquierdo MJ, Farina MC, et al. Papular-purpuric "gloves and socks" syndrome: polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol 1999, 41:793.
171. Saulsbury FT Petechial gloves and socks syndrome caused by parvovirus B19. Pediatr Dermatol 1998, 15:35.
172. Brass C, Elliott LM, Stevens DA Academy rash. A probable epidemic of erythema infectiosum ("fifth disease"). JAMA 1982, 248:568.
173. Tsuji A, Uchida N, Asamura S, et al. Aseptic meningitis with erythema infectiosum. Eur J Pediatr 1990, 149:449.
174. Balfour HH, Schiff GM, Bloom JE Encephalitis associated with erythema infectiosum. JAMA 1970, 77:133.
175. Hall CB, Horner FA Encephalopathy with erythema infectiosum. Am J Dis Child 1977, 131:65.
176. Okumura A, Ichikawa T Aseptic meningitis caused by human parvovirus B19. Arch Dis Child 1993, 68:784.
177. Cassinotti P, Schultze D, Schlageter P, et al. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 1993, 12:701.
178. Watanabe T, Satoh M, Oda Y Human parvovirus B19 encephalopathy. Arch Dis Child 1994, 70:71.
179. Walsh KJ, Armstrong RD, Turner AM Brachial plexus neuropathy associated with human parvovirus infection. Br Med J 1988, 296:896.
180. Faden H, Gary GW, Korman M Numbness and tingling of fingers associated with parvovirus B19 infection. J Infect Dis 1990, 161:354.
181. Dereure O, Montes B, Guilhou JJ Acute generalized livedo reticularis with myasthenia-like syndrome revealing parvovirus B19 primary infection. Arch Dermatol 1995, 131:744.
182. Samii K, Cassinotti P, de Freudenreich J, et al. Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection. Clin Infect Dis 1996, 22:162.
183. Faden H, Gary GW, Anderson LJ Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis 1992, 15:595.
184. Barah F, Vallely PJ, Cleator GM, Kerr JR Neurological manifestations of human parvovirus B19 infection. Rev Med Virol 2003, 13:185.
185. Nakazawa T, Tomosugi N, Sakamoto K, et al. Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis 2000, 35:E31.
186. Komatsuda A, Ohtani H, Nimura T, et al. Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection. Am J Kidney Dis 2000, 36:851.
187. Diaz F, Collazos J Glomerulonephritis and Henoch-Schönlein purpura associated with acute parvovirus B19 infection. Clin Nephrol 2000, 53:237.
188. Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 2000, 35:1166.
189. Anderson LJ, Tsou C, Parker RA, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986, 24:522.
190. Cohen BJ, Bates CM Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J Virol Methods 1995, 55:11.
191. Koch WC A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays. J Virol Methods 1995, 55:67.
192. Jordan JA Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. J Clin Microbiol 2000, 38:1472.
193. Doyle S, Kerr S, O'Keeffe G, et al. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristics analysis. J Virol Methods 2000, 90:143.
194. Clewly JP Detection of human parvovirus using a molecularly cloned probe. J Med Virol 1985, 15:383.
195. Clewly JP Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 1989, 27:2647.
196. Koch WC, Adler SP Detection of human parvovirus B19 DNA by using the polymerase chain reaction. J Clin Microbiol 1990, 28:65.
197. Heegard ED, Hasle H, Clausen N, et al. Parvovirus B19 infection and Diamond-Blackfan anemia. Acta Pediatr 1996, 85:299.
198. Crook TW, Rogers BB, McFarland RD, et al. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients. Hum Pathol 2000, 31:161.
199. Adler SP, Harger JH, Koch WC Infections due to human parvovirus B19 during pregnancy. Infectious Diseases in Women 2001, 100-115. WB Saunders, Philadelphia. M. Martens, S. Faro, D. Soper (Eds.).
200. Schoub BD, Blackburn NK, Johnson S, et al. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa. South Afr Med J 1993, 83:505.
201. Skjoldebrand-Sparre L, Fridell E, Nyman M, Wahren B A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand 1996, 75:336.
202. Mortimer PP, Cohen BJ, Buckley MM, et al. Human parvovirus and the fetus. Letter. Lancet 1985, 2:1012.
203. Wiersbitzky S, Schwarz TF, Bruns R, et al. Seroprävalenz von Antikörpern gegen das humane parvovirus B19 (Ringelröteln/erythema infectiosum) in der DDR-Bevölkerung. Kinderarztl Prax 1990, 58:185.
204. Barros de Freitas R, Buarque de Gusmao SR, Durigon EL, Linhares AC Survey of parvovirus B19 infection in a cohort of pregnant women in Belem, Brazil. Braz J Infect Dis 1999, 3:6.
205. Enders G, Biber M Parvovirus B19 infections in pregnancy. Behring Inst Mitt 1990, 85:74.
206. Rogers BB, Singer DB, Mak SK, et al. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, in situ hybridization, and the polymerase chain reaction. Obstet Gynecol 1993, 81:402.
207. Harger JH, Adler SP, Koch WC, et al. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998, 91:413.
208. Kerr JR, Curran MD, Moore JE Parvovirus B19 infection-persistence and genetic variation. Scand J Infect Dis 1995, 27:551.
209. Schwarz TF, Roggendorf M, Hottentrager B, et al. Human parvovirus B19 infection in pregnancy. Letter. Lancet 1988, 2:566.
210. Gray ES, Anand A, Brown T Parvovirus infections in pregnancy. Letter. Lancet 1986, 1:208.
211. Brown T, Ritchie LD Infection with parvovirus during pregnancy. Br Med J 1985, 290:559.
212. Kinney JS, Anderson LJ, Farrar J, et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 1988, 157:663.
213. Rodis JF, Quinn DL, Gary GW, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990, 163:1168.
214. Torok TJ, Anderson LJ, Gary GW, et al. Reproductive outcomes following human parvovirus B19 infection in pregnancy. Program and Abstracts of 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago 1991, 328. American Society for Microbiology, Washington, DC, (abstract 1374).
215. Xu D, Zhang G, Wang R The study on detection of human parvovirus B19 DNA in spontaneous abortion tissues. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1998, 12:158.
216. Wang R, Chen X, Han M Relationship between human parvovirus B19 infection and spontaneous abortion. Zhonghua Fu Chan Ke Za Zhi 1997, 32:541.
217. De Krijger RR, van Elsacker-Niele AM, Mulder-Staple A, et al. Detection of parvovirus B19 infection in first and second trimester fetal loss. Pediatr Pathol Lab Med 1998, 18:23.
218. Makhseed M, Pacsa A, Ahmed MA, Essa SS Pattern of parvovirus B19 infection during different trimesters of pregnancy in Kuwait. Infect Dis Obstet Gynecol 1997, 7:287.
219. Lowden E, Weinstein L Unexpected second trimester pregnancy loss due to maternal parvovirus B19 infection. South Med J 1997, 90:702.
220. Skjoldebrand-Sparre L, Tolfvenstam T, Papadogiannakis N, et al. Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG 2000, 107:476.
221. Nunoue T, Kusuhara K, Hara T Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J 2002, 21:1133.
222. Norbeck O, Papadogiannakis N, Petersson K, et al. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis 2002, 35:1032.
223. Tolfvenstam T, Papadogiannakis N, Norbeck O, et al. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001, 357:1494.
224. Koch WC, Adler SP, Harger J Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection. Pediatr Infect Dis J 1993, 12:747.
225. Weiland HT, Vermey-Keers C, Salimans MM, et al. Parvovirus B19 associated with fetal abnormality. Letter. Lancet 1987, 1:682.
226. Hartwig NG, Vermeij-Keers C, Van Elsacker-Niele AMW, Gleuren GJ Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology 1989, 39:295.
227. Hartwig NG, Vermeij-Keers C, Versteeg J The anterior eye segment in virus induced primary congenital aphakia. Acta Morphol Neerl Scand 1988-1989, 26:283.
228. Zerbini M, Musiani M, Gentilomi G, et al. Symptomatic parvovirus B19 infection of one fetus in a twin pregnancy. Clin Infect Dis 1993, 17:262.
229. Morey AL, Keeling JW, Porter HJ, Fleming KA Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 1992, 99:566.
230. Rodis JF, Hovick TJ, Quinn DL, et al. Human parvovirus infection in pregnancy. Obstet Gynecol 1988, 72:733.
231. Naides SJ, Weiner CP Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn 1989, 9:105.
232. Katz VL, Chescheir NC, Bethea M Hydrops fetalis from B19 parvovirus infection. J Perinatol 1990, 10:366.
233. Bloom MC, Rolland M, Bernard JD, et al. Infection materno-foetale à parvovirus associée à une péritonite meconiale anétnatale. Arch Fr Pediatr 1990, 47:437.
234. Bernard JD, Berrebi A, Sarramon MF, et al. Infection materno-foetale à parvovirus humain B19: a propos de deux observations. J Gynecol Obstet Biol Reprod 1991, 20:855.
235. Schwarz TF, Nerlich A, Hottenträger B, et al. Parvovirus B19 infection of the fetus: histology and in situ hybridization. Am J Clin Pathol 1991, 96:121.
236. Conry JA, Török T, Andrews PI Perinatal encephalopathy secondary to in utero human parvovirus B-19 (HPV) infection. Neurology 1993, 43(Suppl):A346. (abstract 736S).
237. Török TT Human parvovirus B19. Infectious Diseases of the Fetus and Newborn Infant, 5th ed 2001, 779-811. WB Saunders, Philadelphia. J. Remington, J. Klein (Eds.).
238. Katz VL, McCoy MC, Kuller JA, Hansen WF An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am J Perinatol 1996, 13:43.
239. Rodis JF, Rodner C, Hansen AA, et al. Long-term outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998, 91:125.
240. Porter HJ, Khong TY, Evans MF, et al. Parvovirus as a cause of hydrops fetalis: detection by in situ DNA hybridisation. J Clin Pathol 1988, 41:381.
241. Yaegashi N, Okamura K, Yajima A, et al. The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. J Perinat Med 1994, 22:159.
242. Gloning KP, Schramm T, Brusis E, et al. Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection. Behring Inst Mitt 1990, 85:79.
243. Rogers BB, Mark Y, Oyer CE Diagnosis and incidence of fetal parvovirus infection in an autopsy series. I. Histology. Pediatr Pathol 1993, 13:371.
244. Mark Y, Rogers BB, Oyer CE Diagnosis and incidence of fetal parvovirus infection in an autopsy series. II. DNA amplification. Pediatr Pathol 1993, 13:381.
245. Peters MT, Nicolaides KH Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol 1990, 75:501.
246. Pryde PG, Nugent CE, Pridjian G, et al. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet Gynecol 1992, 79:859.
247. Metzman R, Anand A, DeGiulio PA, Knisely AS Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J Pediatr Gastroenterol Nutr 1989, 9:112.
248. Franciosi RA, Tattersall P Fetal infection with human parvovirus B19. Hum Pathol 1988, 19:489.
249. Zerbini M, Musiani M, Gentilomi G, et al. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996, 34:603.
250. Lewis DB, Wilson CB Developmental immunology and role of host defenses in neonatal susceptibility to infection. Infectious Diseases of the Fetus and Newborn Infant, 4th ed 1995, 20-98. WB Saunders, Philadelphia. J.S. Remington, J.O. Klein (Eds.).
251. Török TJ, Wang Q-Y, Gary GW, et al. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992, 14:149.
252. Morey AL, Patou G, Myint S, Fleming KA In vitro culture for the detection of infectious human parvovirus B19 and B19-specific antibodies using foetal haematopoietic precursor cells. J Gen Virol 1992, 73:3313.
253. Porter HJ, Quantrill AM, Fleming KA B19 parvovirus infection of myocardial cells Letter. Lancet 1988, 1:535.
254. Carrington D, Gilmore DH, Whittle MJ, et al. Maternal serum alpha-fetoprotein-a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet 1987, 1:433.
255. Anderson MJ, Khousam MN, Maxwell DJ, et al. Human parvovirus B19 and hydrops fetalis. Letter. Lancet 1988, 1:535.
256. Sahakian V, Weiner CP, Naides SJ, et al. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Am J Obstet Gynecol 1991, 164:1090.
257. Nerlich AG, Schwarz TF, Hillemanns P, et al. Pathomorphologie der fetalen parvovirus-B19-infektion. Pathologe 1991, 12:204.
258. Berry PJ, Gray ES, Porter HJ, Burton BA Parvovirus infection of the human fetus and newborn. Semin Diagn Pathol 1992, 9:4.
259. Caul EO, Usher MJ, Burton PA Intrauterine infection with human parvovirus B19: a light and electron microscopy study. J Med Virol 1988, 24:55.
260. Maeda H, Shimokawa H, Satoh S, et al. Nonimmunologic hydrops fetalis resulting from intrauterine human parvovirus B-19 infection: report of two cases. Obstet Gynecol 1988, 72:482.
261. van Elsacker-Niele AMW, Salimans MMM, Weiland HT, et al. Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol 1989, 96:768.
262. Bonneau D, Berthier M, Maréchaud M, et al. L'infection à parvovirus B19 au cours de la grossesse. J Gynecol Obstet Biol Reprod 1991, 20:1109.
263. Glaser C, Tannenbaum J Newborn with hydrops and a rash. Pediatr Infect Dis J 1992, 11:980. 984.
264. Nerlich A, Schwarz TF, Roggendorf M, et al. Parvovirus B19-infected erythroblasts in fetal cord blood. Letter. Lancet 1991, 337:310.
265. Morey AL, Fleming KA Immunophenotyping of fetal hematopoietic cells permissive for human parvovirus B19 replication in vitro. Br J Haematol 1992, 82:302.
266. Jordan JA Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996, 174:37.
267. Jordan JA, DeLoia JA Globoside expression within the human placenta. Placenta 1999, 20:103.
268. Jordan JA, Huff D, DeLoia JA Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol 2001, 8:288.
269. Brown KE Human parvovirus B19 infections in infants and children. Adv Pediatr Infect Dis 1998, 13:101.
270. Heegaard ED, Hornsleth A Parvovirus: the expanding spectrum of disease. Acta Paediatr 1995, 84:109.
271. Respondek M, Bratosiewicz J, Pertynski T, Liberski PP Parvovirus particles in a fetal heart with myocarditis: ultrastructural and immunohistochemical study. Arch Immunol Ther Exp (Warsz) 1997, 45:465.
272. Porter HJ, Quantrill AM, Fleming KA B19 Parvovirus infection of myocardial cells. Lancet 1988, 535.
273. Nigro G, Bastianon V, Colloridi1 V, et al. Acute and chronic lymphocytic myocarditis in infancy is associated with parvovirus B19 infection and high cytokine levels. Clin Infect Dis 2000, 31:65.
274. Heegaard ED, Eiskjaer H, Baandrup U, Hornsleth A Parvovirus B19 infection associated with myocarditis following adult cardiac transplantation. Scand J Infect Dis 1998, 30:607.
275. Papadogiannakis N, Tolfvenstam T, Fischler B, et al. Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant. Clin Infect Dis 2002, 35:1027.
276. Kovacs BW, Carlson DE, Shahbahrami B, Platt LD Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction. Am J Obstet Gynecol 1992, 167:461.
277. Wang X, Zhang G, Han M, et al. Investigation of parvovirus B19 in cardiac tissue from patients with congenital heart disease. Chin Med J (Engl) 1999, 112:995.
278. Humphrey W, Magoon M, O'Shaughnessy R Severe nonimmune hydrops secondary to parvovirus B-19 infection: spontaneous reversal in utero and survival of a term infant. Obstet Gynecol 1991, 78:900.
279. Plachouras N, Stefanidis K, Andronikou S, Lolis D Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A case report. J Reprod Med 1999, 44:377.
280. Miyagawa S, Takahashi Y, Nagai A, et al. Angio-oedema in a neonate with IgG antibodies to parvovirus B19 following intrauterine parvovirus B19 infection. Br J Dermatol 2000, 143:428.
281. Sheikh AU, Ernest JM, O'Shea M Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 1992, 167:337.
282. Bernstein IA, Capeless EL Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B19 infection. Obstet Gynecol 1989, 774:456.
283. Carrington D, Whittle MJ, Gibson AAM, et al. Maternal serum alpha feto-protein: a marker of fetal aplastic crisis during uterine human parvovirus infection. Lancet 1987, 1:433.
284. Komischke K, Searle K, Enders G Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications. Prenat Diagn 1997, 17:1039.
285. Dembinski J, Haverkamp F, Maara H, et al. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. Br J Obstet Gynaecol 2002, 109:1232.
286. Kovacs BW, Carlson DE, Shahbahrami B, et al. Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction. Am J Obstet Gynecol 1992, 167:461.
287. Humphrey W, Magoon M, O'Shaughnessy R Severe nonimmune hydrops secondary to parvovirus B-19 infection: spontaneous reversal in utero and survival of a term infant. Obstet Gynecol 1991, 78:900.
288. Morey AL, Nicolini U, Welch CR, et al. Parvovirus B19 infection and transient fetal ascites. Lancet 1991, 337:496.
289. Schwartz TF, Roggendorf M, Hottentrager B, et al. Human parvovirus B19 infection in pregnancy. Lancet 1988, 2:566.
290. Soothill P Intrauterine blood transfusion for non-immune hydrops fetalis due to parvovirus B19 infection. Lancet 1990, 356:121.
291. Sahakian V, Weiner CP, Naides SJ, et al. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Amer J Obstet Gynecol 1991, 164:1090.
292. Vogel H, Kornman M, Ledet SC, et al. Congenital parvovirus infection. Pediatr Pathol Lab Med 1997, 17:903.
293. Miller E, Fairley CK, Cohen BJ, Seng C Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998, 105:14.
294. Ballou WR, Reed JL, Noble W, et al. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 2003, 187:675.
295. Bond PR, Caul EO, Usher I, et al. Intrauterine infection with human parvovirus. Letter. Lancet 1986, 1:448.
296. Woernle CH, Anderson LJ, Tattersall P, et al. Human parvovirus B19 infection during pregnancy. J Infect Dis 1987, 156:17.
297. Maeda H, Shimokawa H, Satoh S, et al. Nonimmunologic hydrops fetalis resulting from intrauterine human parvovirus B19 infection: report of 2 cases. Obstet Gynecol 1988, 71:482.
298. Samra JS, Obhrai MS, Constantine G Parvovirus infection in pregnancy. Obstet Gynecol 1989, 73:832.
299. Mortimer PP, Cohen BJ, Buckley MM, et al. Human parvovirus and the fetus. Lancet 1985, 2:1012.
300. Weiner CP, Naides SJ Fetal survival after human parvovirus B19 infection: spectrum of intrauterine response in a twin gestation. Am J Perinatol 1992, 9:66.